Cargando…
Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations
Cerebral cavernous malformations (CCMs) are vascular lesions in the central nervous system causing strokes and seizures which currently can only be treated through neurosurgery. The disease arises through changes in the regulatory networks of endothelial cells that must be comprehensively understood...
Autores principales: | Otten, Cécile, Knox, Jessica, Boulday, Gwénola, Eymery, Mathias, Haniszewski, Marta, Neuenschwander, Martin, Radetzki, Silke, Vogt, Ingo, Hähn, Kristina, De Luca, Coralie, Cardoso, Cécile, Hamad, Sabri, Igual Gil, Carla, Roy, Peter, Albiges‐Rizo, Corinne, Faurobert, Eva, von Kries, Jens P, Campillos, Mónica, Tournier‐Lasserve, Elisabeth, Derry, W Brent, Abdelilah‐Seyfried, Salim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180302/ https://www.ncbi.nlm.nih.gov/pubmed/30181117 http://dx.doi.org/10.15252/emmm.201809155 |
Ejemplares similares
-
Impaired retinoic acid signaling in cerebral cavernous malformations
por: Grdseloff, Nastasja, et al.
Publicado: (2023) -
CCM1–ICAP-1 complex controls β1 integrin–dependent endothelial contractility and fibronectin remodeling
por: Faurobert, Eva, et al.
Publicado: (2013) -
Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice
por: Boulday, Gwénola, et al.
Publicado: (2011) -
Network-based analysis of omics data: the LEAN method
por: Gwinner, Frederik, et al.
Publicado: (2017) -
Recalibrating vascular malformations and mechanotransduction by pharmacological intervention
por: Abdelilah-Seyfried, Salim, et al.
Publicado: (2022)